Oncopeptides AB (ONCO.ST) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Sweden · ISIN SE0009414576
Oncopeptides AB financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 31.65 m SEK | 71.12 m SEK |
| Gross profit | 28.99 m SEK | 59.00 m SEK |
| Operating income | -283.50 m SEK | -225.89 m SEK |
| EBIT | -271.55 m SEK | -228.93 m SEK |
| Net income | -284.61 m SEK | -249.59 m SEK |
| Diluted EPS – continuing operations | -1.71 SEK | -1.10 SEK |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Oncopeptides AB
Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for with an alkylating payload, developed for the treatment of adult patients with multiple myeloma. The company's PDC platform designed with two components, peptide carrier and a cytotoxic payload which utilizes the altered metabolism of cancer cells to hydrolyze PDC into active hydrophilic metabolites, which lead to an enrichment in cancer cells. It offers OPD5, OPDC3, and Gliopep for the treatment of hematological or solid tumors, and glioblastoma. The company also provides Small Polypeptide based Killer Engagers (SPiKE) platform that is designed to bind to both NK-cells and specific targets on various cancer cells. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.
More stocks
- Pathfinder Bancorp, Inc. (PBHC)
- Advanced Analog Technology (3438.TWO)
- Tech-Top Engineering CO., LTD (6750.TWO)
- Hwashin Precision Engineering Co. Ltd (126640.KQ)
- SysJust Co., Ltd. (3158.TWO)
- SERA PROGNOSTICS, INC. (SERA)
- Mikobeaute International Co., Ltd. (6574.TWO)
- Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)
- Coya Therapeutics, Inc. (COYA)
- Lucent, Inc. (LUCN)
- Powerlogics Co. Ltd (047310.KQ)
- EDU Holdings Ltd (EDU.AX)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.